Health: Respiratory Disease
House of Lords

Photo of Baroness Thornton

Baroness Thornton (Labour)

To ask Her Majesty's Government what is their assessment of the efficacy of current standard forms of treatment for idiopathic pulmonary fibrosis.

Photo of Earl Howe

Earl Howe (Conservative)

The department has made no assessment of the efficacy of current standard forms of treatment for idiopathic pulmonary fibrosis (IPF). It is the responsibility of local National Health Service organisations to make decisions on the commissioning and funding of any health care treatments for NHS patients.

The National Institute for Health and Clinical Excellence (NICE) is developing technology appraisal guidance on the use of pirfenidone (Esbriet) for the treatment of patients with mild to moderate IPF. NICE issued initial draft guidance for consultation on 29 November 2012 that does not recommend the drug and currently expects to issue final guidance in April 2013.

Annotations

No annotations

Sign in or join to post a public annotation.